http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2758260-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e79b095349226032cd379f8d0af6209 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate | 2020-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a11e56ed3dd804291580c941afa8fa6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14fde53dbff070c54af5a9f5f9dd79f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e73966aface5ffab1e3e71e0612498da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6726c21adab1f0033b528cb380139464 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d03b3b3a902246e62038af4aceab499 |
| publicationDate | 2021-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2758260-C1 |
| titleOfInvention | Method for producing autologous fibrin with controlled fibrinogen content without using exogenous thrombin |
| abstract | FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to a method for producing autologous fibrin with controlled fibrinogen content. A method for producing autologous fibrin with controlled fibrinogen content without the use of exogenous thrombin includes blood sampling with sodium citrate, obtaining platelet-rich blood plasma by centrifugation, isolation of precipitate from blood plasma by ethanol precipitation with a low ethanol content, incubation with constant stirring and centrifugation, concentration control fibrinogen in the precipitate by diluting with a buffer, adding a solution of calcium chloride under certain conditions.EFFECT: method makes it possible to obtain an autologous, biocompatible and safe fibrin for regenerative and tissue engineering, having a controlled composition and having a high integration with the host organism.1 cl, 3 dwg, 3 ex |
| priorityDate | 2020-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.